Results 131 to 140 of about 1,044,683 (223)

Distinct safety profiles of albumin-bound nab-paclitaxel and paclitaxel in pancreatic cancer focusing on hematologic and hepatobiliary risks

open access: yes
Nab-paclitaxel (albumin-bound paclitaxel) and traditional paclitaxel are both used in pancreatic cancer treatment, but their adverse event (AE) profiles may differ due to formulation differences.
Jingtao Chen, Zhongliu Bian, Nan Qin
core   +1 more source

Intensity-modulated radiotherapy combined with albumin-bound paclitaxel and platinum-based chemotherapy for locoregional recurrent cervical cancer: a single-institutional phase II investigator-initiated nonrandomized clinical trial

open access: yes
Objective To prospectively explore efficacy and safety of radiotherapy combined with albumin-bound paclitaxel and platinum-based chemotherapy for locoregional recurrent cervical cancer (CC).
Xiaohua Wu   +5 more
core   +1 more source

Population pharmacokinetics and pharmacodynamics of intraperitoneal aerosolized nanoparticle albumin-bound paclitaxel (nab-PTX) and metabolites. [PDF]

open access: yesBr J Clin Pharmacol
De Sutter PJ   +10 more
europepmc   +1 more source

A phase II clinical trial of albumin-bound paclitaxel, cisplatin, gemcitabine (NABPLAGEM), and paricalcitol as neoadjuvant therapy in pancreatic cancer. [PDF]

open access: yesOncologist
Viniotis AF   +20 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy